Catatonia in systemic lupus erythematosus: a case report and review of literature.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 634, doi. 10.1177/0961203313486951
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2013 AND VI 22 AND IP 6
Results: 14
1
2
Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 639, doi. 10.1177/0961203313486950
- By:
- Publication type:
- Article
3
Systemic lupus erythematosus associated with moyamoya syndrome: a case report and literature review.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
4
Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.
- Published in:
- 2013
- Publication type:
- Correction Notice
5
Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 554, doi. 10.1177/0961203313480398
- By:
- Publication type:
- Article
6
Pediatric lupus nephritis: more options, more chances?
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 545, doi. 10.1177/0961203313485490
- By:
- Publication type:
- Article
7
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 607, doi. 10.1177/0961203313484978
- By:
- Publication type:
- Article
8
Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 614, doi. 10.1177/0961203313484977
- By:
- Publication type:
- Article
9
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 574, doi. 10.1177/0961203313483376
- By:
- Publication type:
- Article
10
High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 597, doi. 10.1177/0961203313483377
- By:
- Publication type:
- Article
11
Estradiol differentially regulates calreticulin: a potential link with abnormal T cell function in systemic lupus erythematosus?
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 583, doi. 10.1177/0961203313482742
- By:
- Publication type:
- Article
12
Rituximab treatment for ‘rhupus syndrome’: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 624, doi. 10.1177/0961203313482741
- By:
- Publication type:
- Article
13
Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: a functional magnetic resonance imaging study.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 562, doi. 10.1177/0961203313480399
- By:
- Publication type:
- Article
14
Temporal trends in characteristics and outcome of intensive care unit patients with systemic lupus erythematosus in Taiwan: a national population-based study.
- Published in:
- Lupus, 2013, v. 22, n. 6, p. 644, doi. 10.1177/0961203313476356
- By:
- Publication type:
- Article